← 產業報告目錄
Inhalation CDMO Market Size, Share & Trends Analysis Report, By Product (API, Inhalation Platform), By Services (Formulation Development, Device Development and Manufacturing, Clinical Manufacturing, Scale-up and Tech Transfer, Quality Control and Quality Assurance, Technology and Innovation, Regulatory Assistance, Analytical Services), By Company Size, By Scale of Operation, By Region, Forecasts, 2024-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-01-05頁數 178報告編號 INSIGHTACE-1247895eb6
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The worldwide Inhalation CDMO Market stood at USD 7.9 Bn in 2023, and is poised to reach USD 11.8 Bn by 2031, recording a CAGR of 5.2% from 2024 through 2031.
At its core, Inhalation CDMO pertains to the organization that is responsible for the development and manufacturing of inhalation contracts. Stakeholders across the healthcare landscape are risingly turning to these solutions to meet contemporary demands.
Market momentum is bolstered by rising need advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, bolstered by rapid industrialization and expanding end-user bases.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Inhalation CDMO Market Snapshot
Chapter 4. Global Inhalation CDMO Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Product Estimates & Trend Analysis
5.1. By Product & Market Share, 2023 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Product:
5.2.1. API
5.2.1.1. API Substrate
5.2.1.2. Large Molecule
5.2.1.3. Small Molecule
5.2.2. Inhalation Platform
5.2.2.1. Dry Powder Inhaler (DPIs)
5.2.2.2. Metered Dose Inhaler (MDIs)
5.2.2.3. Soft Mist Inhaler
Chapter 6. Market Segmentation 2: By Service Estimates & Trend Analysis
6.1. By Service & Market Share, 2023 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Service:
6.2.1. Formulation Development
6.2.2. Device Development and Manufacturing
6.2.3. Clinical Manufacturing
6.2.4. Scale-up and Tech Transfer
6.2.5. Quality Control and Quality Assurance
6.2.6. Technology and Innovation
6.2.7. Regulatory Assistance
6.2.8. Analytical Services
Chapter 7. Market Segmentation 3: By Company Size Estimates & Trend Analysis
7.1. By Company Size & Market Share, 2023 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Company Size:
7.2.1. Large
7.2.2. Medium
7.2.3. Small
Chapter 8. Market Segmentation 4: by Scale of Operation Estimates & Trend Analysis
8.1. by Scale of Operation & Market Share, 2023 & 2031
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Scale of Operation:
8.2.1. Preclinical
8.2.2. Clinical
8.2.3. Commercial
Chapter 9. Inhalation CDMO Market Segmentation 4: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Inhalation CDMO Market Revenue (US$ Million) Estimates and Forecasts by Product, 2024-2031
9.1.2. North America Inhalation CDMO Market Revenue (US$ Million) Estimates and Forecasts by Scale of Operation, 2024-2031
9.1.3. North America Inhalation CDMO Market Revenue (US$ Million) Estimates and Forecasts by Service, 2024-2031
9.1.4. North America Inhalation CDMO Market Revenue (US$ Million) Estimates and Forecasts by Company Size, 2024-2031
9.1.5. North America Inhalation CDMO Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
9.2. Europe
9.2.1. Europe Inhalation CDMO Market Revenue (US$ Million) Estimates and Forecasts by Product, 2024-2031
9.2.2. Europe Inhalation CDMO Market Revenue (US$ Million) Estimates and Forecasts by Scale of Operation, 2024-2031
9.2.3. Europe Inhalation CDMO Market Revenue (US$ Million) Estimates and Forecasts by Service, 2024-2031
9.2.4. Europe Inhalation CDMO Market Revenue (US$ Million) Estimates and Forecasts by Company Size, 2024-2031
9.2.5. Europe Inhalation CDMO Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
9.3. Asia Pacific
9.3.1. Asia Pacific Inhalation CDMO Market Revenue (US$ Million) Estimates and Forecasts by Product, 2024-2031
9.3.2. Asia Pacific Inhalation CDMO Market Revenue (US$ Million) Estimates and Forecasts by Scale of Operation, 2024-2031
9.3.3. Asia Pacific Inhalation CDMO Market Revenue (US$ Million) Estimates and Forecasts by Service, 2024-2031
9.3.4. Asia Pacific Inhalation CDMO Market Revenue (US$ Million) Estimates and Forecasts by Company Size, 2024-2031
9.3.5. Asia Pacific Inhalation CDMO Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
9.4. Latin America
9.4.1. Asia Pacific Inhalation CDMO Market Revenue (US$ Million) Estimates and Forecasts by Product, 2024-2031
9.4.2. Asia Pacific Inhalation CDMO Market Revenue (US$ Million) Estimates and Forecasts by Scale of Operation, 2024-2031
9.4.3. Latin America Inhalation CDMO Market Revenue (US$ Million) Estimates and Forecasts by Service, 2024-2031
9.4.4. Latin America Inhalation CDMO Market Revenue (US$ Million) Estimates and Forecasts by Company Size, 2024-2031
9.4.5. Latin America Inhalation CDMO Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
9.5. Middle East & Africa
9.5.1. Middle East & Africa Inhalation CDMO Market Revenue (US$ Million) Estimates and Forecasts by Product, 2024-2031
9.5.2. Middle East & Africa Inhalation CDMO Market Revenue (US$ Million) Estimates and Forecasts by Scale of Operation, 2024-2031
9.5.3. Middle East & Africa Inhalation CDMO Market Revenue (US$ Million) Estimates and Forecasts by Service, 2024-2031
9.5.4. Middle East & Africa Inhalation CDMO Market Revenue (US$ Million) Estimates and Forecasts by Company Size, 2024-2031
9.5.5. Middle East & Africa Inhalation CDMO Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Recipharm AB
10.2.2. AptarGroup Inc.
10.2.3. Hovione
10.2.4. Vectura Group Ltd
10.2.5. Nemera
10.2.6. Kindeva
10.2.7. H&T Presspart
10.2.8. Sanner GmbH
10.2.9. Stevanato Group
10.2.10. Medspray
10.2.11. ICONOVO AB
10.2.12. Lonza
10.2.13. Gerresheimer AG
10.2.14. Catalent
10.2.15. Thermo Fisher Scientific Inc.
10.2.16. Lubrizol Life Science
10.2.17. Enteris BioPharma
10.2.18. Cambrex Corporation
10.2.19. INKE
10.2.20. Piramal Pharma Limited
10.2.21. Lupin
10.2.22. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們